Higher risk individuals include those with any personal cancer history, strong hereditary cancer syndromes, multiple first-degree relatives with cancer, or those significantly behind on age-appropriate screening
Reagents Adenosine dialdehyde (AdOx) (Sigma, #A7154), SGC3027 (MedChemExpress, #HY-112445), Compound C (MedChemExpress, #HY-13418A), Wortmannin (Topscience, #T6283), Ipatasertib dihydrochloride (Topscience, #T15374), metformin (Sangon Biotech, #A414520), insulin (Topscience, #T8221), glucose (Topscience, #T0887), docetaxel (MCE, #HY-B0011), PreScission Protease with GST tag (Beyotime Biotechnology, #P2302), Ni-NTA 6FF (His-Tag) (Sangon Biotech, #C600033) and glutathione-Sepharose 4B beads (Beyotime Biotechnology, #P2258) were commercially obtained
Avoid becoming pregnant during and within one month after stopping treatment
For the purposes of clinical studies, as well as routine practice, the Neuropathy Disability Score (NDS) was developed (Table 3)